Status: Recruiting
Pilot Clinical Trial to Assess the Safety of NMS-01 in Patients With Mild to Moderate Alzheimer's Disease
A single-center, single-arm, prospective, open-label, pilot clinical trial to evaluate the safety and efficacy of the Focused ultrasound stimulator system (NMS-01) for transient Blood-Brain Barrier (BBB) opening in patients with mild to moderate Alzheimer's disease
Participants needed: 10
Trial details
Age: 50-85Biological sex: AllType: InterventionalSponsor: Neumous Inc.Updated: Oct 9, 2026Locations: 1
Eligibility criteria
Adults aged 50 to 85 years, inclusive. [+8]
A severity score greater than 2 on any one of the following items on the Caregiv... [+19]